Skip to main content
Premium Trial:

Request an Annual Quote

Tekmira Receives FDA Fast Track Designation for Ebola Drug

Premium

Tekmira Pharmaceuticals this week announced that it has received a fast track designation for its phase I Ebola virus drug TKM-Ebola from the US Food and Drug Administration.

The designation is designed to facilitate the development and expedite the review of drugs to treat serious conditions and fill an unmet medical need, according to the FDA. The developers of eligible drugs may receive, among other things, more frequent meetings and correspondence with agency officials.

In January, Tekmira began testing TKM-Ebola in a phase I study. Data from the trial is expected in the second half of the year.

The Scan

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.

Effectiveness May Decline, Data From Israel Suggests

The New York Times reports that new Israeli data suggests a decline in Pfizer-BioNTech SARS-CoV-2 vaccine effectiveness against Delta variant infection, though protection against severe disease remains high.

To See Future Risk

Slate looks into the use of polygenic risk scores in embryo screening.

PLOS Papers on Methicillin-Resistant Staphylococcus, Bone Marrow Smear Sequencing, More

In PLOS this week: genomic analysis of methicillin-resistant Staphylococcus pseudintermedius, archived bone marrow sequencing, and more.